| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Jun―22 |
Modeling the impact of the COVID-19 pandemic on achieving HCV elimination amongst young and unstably housed people who inject drugs in San Francisco |
Hannah Fraser, Jack Stone, Shelley N Facente, Adelina Artenie, Sheena Patel, Erin C Wilson, Willi McFarland, Kimberly Page, Peter Vickerman, Meghan D Morris |
| 2 |
[GO] |
2024―Jun―20 |
Structural violence and necropolitics among Indigenous Peoples living with HIV who use substances in the Prairie provinces during COVID-19 |
Samantha Moore, Tara Christianson, Rusty Souleymanov |
| 3 |
[GO] |
2024―Jun―13 |
Changes in the incidence of cannabis-related disorders after the Cannabis Act and the COVID-19 pandemic in Québec, Canada |
Pablo Martínez, Chris Huynh, Victoria Massamba, Isaora Zefania, Louis Rochette, Helen-Maria Vasiliadis, José Ignacio Nazif-Munoz |
| 4 |
[GO] |
2024―Mar―26 |
Alcohol policy changes during the first three-months of the COVID-19 pandemic: Development and application of a classification scheme |
Sebastián Peña, Claire Wilkinson, Giovanni Aresi, Liz Barrett, Sadie Boniface, Niamh Fitzgerald, Pablo Norambuena, Catherine Paradis, Francisca Román, Paula Sierralta |
| 5 |
[GO] |
2024―Mar―23 |
Trends in opioid toxicities among people with and without opioid use disorder and the impact of the COVID-19 pandemic in Ontario, Canada: A population-based analysis |
Shaleesa Ledlie, Mina Tadrous, Ahmed M. Bayoumi, Daniel McCormack, Clare Cheng, Jes Besharah, Charlotte Munro, Tara Gomes |
| 6 |
[GO] |
2024―Mar―13 |
An ecological study of the correlation between COVID-19 support payments and overdose events in British Columbia, Canada |
Lindsey Richardson, Cameron Geddes, Heather Palis, Jane Buxton, Amanda Slaunwhite |
| 7 |
[GO] |
2024―Mar―05 |
Volatile drug use and overdose during the first year of the COVID-19 pandemic in the United States |
Kristin E. Schneider, Emily M. Martin, Sean T. Allen, Miles Morris, Katherine Haney, Brendan Saloner, Susan G. Sherman |
| 8 |
[GO] |
2024―Jan―05 |
Adoption of methadone take home policy by U.S. state opioid treatment authorities during COVID-19 |
Victor Roy, Michele Buonora, Caty Simon, Bridget Dooling, Paul Joudrey |
| 9 |
[GO] |
2023―Nov―25 |
Understanding problematic substance use among first responders during the COVID-19 pandemic: A survey of law enforcement, fire, and EMS workers in the United States |
Kaila Witkowski, Ryan J. Lofaro, Andrea M. Headley, Santina Contreras, Christa L. Remington, N．Emel Ganapati |
| 10 |
[GO] |
2023―Oct―27 |
Restrictive measures and substance use reporting: New evidence from the COVID-19 pandemic |
Andrea Rebucini, Federica Origo, Francesca Schionato, Francesco Saverio Romolo |
| 11 |
[GO] |
2023―Oct―03 |
Negative changes in illicit drug supply during COVID-19: Associations with use of overdose prevention and health services among women sex workers who use drugs (2020-2021) |
Sarah Moreheart, Kate Shannon, Andrea Krüsi, Jennifer McDermid, Emma Ettinger, Melissa Braschel, Shira Miriam Goldenberg |
| 12 |
[GO] |
2023―Aug―11 |
Challenges of implementing safer supply programs in Canada during the COVID-19 pandemic: A qualitative analysis |
Mohammad Karamouzian, Bijan Rafat, Gillian Kolla, Karen Urbanoski, Kate Atkinson, Geoff Bardwell, Matthew Bonn, Natasha Touesnard, Nancy Henderson, Jeanette Bowles, Jade Boyd, Caroline Brunelle, Jolene Eeuwes, Jill Fikowski, Tara Gomes, Adrian Guta, Elaine Hyshka, Andrew Ivsins, Mary Clare Kennedy, Gab Laurence, Lucas Martignetti, Frishta Nafeh, Kate Salters, David Tu, Carol Strike, Bernadette Pauly, Dan Werb |
| 13 |
[GO] |
2023―Jul―18 |
Residence in urban or rural counties in relation to opioid overdose mortality among Kentucky hospitalizations before and during the COVID-19 pandemic |
Lyndsey K. Blair, Jeffrey Howard, Nicholas C. Peiper, Bert B. Little, Kira C. Taylor, Richard Baumgartner, Liza Creel, Natalie C. DuPre |
| 14 |
[GO] |
2023―Jun―08 |
General hospital admissions in young and middle-aged people who use psychoactive substances: impact of Covid-19 lockdowns |
J Perino, H Ramaroson, N Ong, J Bezin, V Gilleron, A Daveluy, M Tournier |
| 15 |
[GO] |
2023―May―22 |
A new outbreak of HIV infection among people who inject drugs during the COVID-19 pandemic in Greece |
Vana Sypsa, Sotirios Roussos, Efrossini Tsirogianni, Chrissa Tsiara, Dimitra Paraskeva, Theofilos Chrysanthidis, Dimitrios Chatzidimitriou, Evaggelia Papadimitriou, Dimitrios Paraskevis, Ioannis Goulis, George Kalamitsis, Angelos Hatzakis |
| 16 |
[GO] |
2023―May―22 |
Impacts of the COVID-19 pandemic on enrollment in medications for opioid use disorder (MOUD) in Vancouver, Canada: an interrupted time series analysis |
M. Eugenia SOCIAS, Jin Cheol CHOI, Nadia FAIRBAIRN, Cheyenne JOHNSON, Dean WILSON, Kora DEBECK, Rupinder BRAR, Kanna HAYASHI |
| 17 |
[GO] |
2023―May―15 |
The impacts of COVID-19 on structural inequities faced by people living with HIV who inject drugs: A qualitative study in St. Petersburg, Russia |
Jennifer J. Carroll, Sarah L. Rossi, Marina V. Vetrova, Elena Blokhina, Yuliia Sereda, Dmitry Lioznov, Jason Luoma, Tetiana Kiriazova, Karsten Lunze |
| 18 |
[GO] |
2023―May―08 |
Provider experiences with relaxing restrictions on take-home medications for opioid use disorder during the COVID-19 pandemic: A qualitative systematic review |
Alison Adams, Sarin Blawatt, Scott MacDonald, Rhys Finnick, Julie Lajeunesse, Scott Harrison, David Byres, Martin T. Schechter, Eugenia Oviedo-Joekes |
| 19 |
[GO] |
2023―May―08 |
What's in Stock? Drug drought anticipation during COVID-19 among people who use drugs and service providers |
Maj Nygaard-Christensen, Thomas Friis Søgaard |
| 20 |
[GO] |
2023―May―05 |
Impact of COVID-19 on Poisoning-Related Mortality in Iran: An Interrupted Time Series Study |
Amir Hossein Behnoush, Elham Bazmi, Mehdi Forouzesh, Steven A Koehler, Seyed Jalil Monabati, Behnam Behnoush |
| 21 |
[GO] |
2023―Apr―26 |
Public Transport Access to Drug Treatment Before and During COVID-19: Implications for the Opioid Epidemic |
Yücel Shiv Gazi, Christopher D. Higgins, Gupta Kumar, Matthew Palm |
| 22 |
[GO] |
2023―Apr―07 |
Public health interventions, priority populations, and the impact of COVID-19 disruptions on hepatitis C elimination among people who have injected drugs in Montreal (Canada): a modeling study |
Charlotte Lanièce Delaunay, Marina B. Klein, Arnaud Godin, Joseph Cox, Nadine Kronfli, Bertrand Lebouché, Carla Doyle, Mathieu Maheu-Giroux |
| 23 |
[GO] |
2023―Apr―03 |
Risk mitigation guidance and safer supply prescribing among young people who use drugs in the context of COVID-19 and overdose emergencies |
Karen Giang, Reith Charlesworth, Madison Thulien, Alanna Mulholland, Brittany Barker, Rupinder Brar, Bernie Pauly, Danya Fast |
| 24 |
[GO] |
2023―Mar―06 |
“You'll come in and dose even in a global pandemic”: a qualitative study of adaptive opioid agonist treatment provision during the COVID-19 pandemic |
Anna Conway, Carla Treloar, Sione Crawford, Louisa Degenhardt, Gregory J Dore, Michael Farrell, Jeremy Hayllar, Jason Grebely, Alison D. Marshall |
| 25 |
[GO] |
2023―Mar―05 |
Changes in hazardous drinking pre, during and post 70-day alcohol sales ban during COVID-19 pandemic in Botswana |
J. Maphisa Maphisa, Thokozani B.H. Ndlovu |
| 26 |
[GO] |
2023―Feb―16 |
Disruption to Australian heroin, methamphetamine, cocaine and ecstasy markets with the COVID-19 pandemic and associated restrictions |
Olivia Price, Nicola Man, Rachel Sutherland, Raimondo Bruno, Paul Dietze, Caroline Salom, Seraina Agramunt, Jodie Grigg, Louisa Degenhardt, Amy Peacock |
| 27 |
[GO] |
2022―Nov―22 |
Increased Solitary Drug Use during COVID-19: An Unintended Consequence of Social Distancing |
Kristin E. Schneider, Sean T. Allen, Saba Rouhani, Miles Morris, Katherine Haney, Brendan Saloner, Susan G. Sherman |
| 28 |
[GO] |
2022―Oct―20 |
How Covid-19 restrictions affected young people's well-being and drinking practices? Analyzing interview material with a socio-material approach |
Jukka Törrönen, Josefin Månsson, Eva Samuelsson, Filip Roumeliotis, Johan Svensson, Ludwig Kraus, Robin Room |
| 29 |
[GO] |
2022―Oct―17 |
A stakeholder-driven framework for measuring potential change in the health risks of people who inject drugs (PWID) during the COVID-19 pandemic |
Heather Bradley, Chelsea Austin, Sean T. Allen, Alice Asher, Tyler S. Bartholomew, Amy Board, Annick Borquez, Kate Buchacz, Anastasia Carter, Hannah L.F. Cooper, Judith Feinberg, Nathan Furukawa, Becky Genberg, Holly Hagan, Emalie Huriaux, Hermione Hurley, Nicole Luisi, Natasha K. Martin, Eli S. Rosenberg, Steffanie A. Strathdee, Don C. Des Jarlais |
| 30 |
[GO] |
2022―Oct―17 |
Changes in supervised consumption site use and emergency interventions in Montréal, Canada in the first twelve months of the COVID-19 pandemic: An interrupted time series study |
Camille Zolopa, Thomas D. Brothers, Pascale Leclerc, Jean-François Mary, Carole Morissette, Julie Bruneau, Elaine Hyshka, Natasha K. Martin, Sarah Larney |
| 31 |
[GO] |
2022―Oct―04 |
Methadone and buprenorphine-related deaths among people prescribed and not prescribed Opioid Agonist Therapy during the COVID-19 pandemic in England |
D Aldabergenov, L Reynolds, J Scott, MJ Kelleher, J Strang, CS Copeland, NJ Kalk |
| 32 |
[GO] |
2022―Sep―21 |
“Maintaining HIV and HCV prevention and care for people who inject drugs despite COVID-19 in Hai Phong, Vietnam” |
Hoang Thi Giang, Nguyen Quang Duc, Jean-Pierre Molès, Vu Hai Vinh, Nicolas Nagot, Nham Thi Tuyet Thanh, Duong Thi Huong, Khuat Thi Hai Oanh, Pham Minh Khue, Le Sao Mai, Nguyen Thu Trang, Pham Thi Ngoc, Catherine Quillet, Jonathan Feelemyer, Roselyne Vallo, Laurent Michel, Don Des Jarlais, Didier Laureillard, Delphine Rapoud |
| 33 |
[GO] |
2022―Aug―23 |
Mortality by Cause of Death during Year 1 of the COVID-19 Pandemic in a Cohort of Older Adults from Baltimore Maryland who Have Injected Drugs |
Kenneth A. Feder, Jing Sun, Jacqueline E. Rudolph, Javier Cepeda, Jacquie Astemborski, Pieter A. Baker, Damani A. Pigott, Gregory D. Kirk, Shruti H. Mehta, Becky L. Genberg |
| 34 |
[GO] |
2022―Aug―15 |
Impact of COVID-19 on the Characteristics of Opioid Overdose Deaths in Arkansas |
Mandana Rezaeiahari, Brian J. Fairman |
| 35 |
[GO] |
2022―Aug―10 |
Barriers to engaging people who use drugs in harm reduction services during the COVID-19 pandemic: A mixed methods study of syringe services program perspectives |
Elizabeth J. Austin, Maria A. Corcorran, Elsa S. Briggs, Madeline C. Frost, Czarina N. Behrends, Alexa M. Juarez, Noah D. Frank, Elise Healy, Stephanie M. Prohaska, Paul A. LaKosky, Shashi N. Kapadia, David C. Perlman, Bruce R. Schackman, Don C. Des Jarlais, Emily C. Williams, Sara N. Glick |
| 36 |
[GO] |
2022―Aug―08 |
COVID-19 and the opportunity for gender-responsive virtual and remote substance use treatment and harm reduction services |
Melissa Perri, Rose A. Schmidt, Adrian Guta, Natalie Kaminski, Katherine Rudzinski, Carol Strike |
| 37 |
[GO] |
2022―Aug―03 |
SUBSTANCE USE AND HOMELESSNESS: A LONGITUDINAL INTERVIEW STUDY CONDUCTED DURING COVID-19 WITH IMPLICATIONS FOR POLICY AND PRACTICE |
Joanne Neale, Stephen Parkin, Laura Hermann, Nicola Metrebian, Emmert Roberts, Deborah Robson, John Strang |
| 38 |
[GO] |
2022―Jul―01 |
A rapid assessment of take-home naloxone provision during COVID-19 in Europe |
Rebecca McDonald, Desiree Eide, Katri Abel-Ollo, Lee Barnsdale, Ben Carter, Thomas Clausen, Ed Day, Francina Fonseca, Elin Holmén, Kirsten Horsburgh, Mike Kelleher, Martin Kåberg, Martin Ladenhauf, Andrew McAuley, Nicola Metrebian, Joanne Neale, Stephen Parkin, Kevin Ratcliffe, Chris Rintoul, Josie Smith, Viktorija Stifanoviciute, Marta Torrens, Henrik Thiesen, John Strang |
| 39 |
[GO] |
2022―Jun―16 |
COVID-19 economic impact payments and opioid overdose deaths: a response |
Jon E. Sprague, Arthur B. Yeh, Qizhen Lan, Jamie Vieson, Maggie McCorkle |
| 40 |
[GO] |
2022―Jun―16 |
Consensus recommendations for opioid agonist treatment following the introduction of emergency clinical guidelines in Ireland during the COVID-19 pandemic: a national Delphi study |
Louise Durand, Eamon Keenan, Fiona Boland, Norma Harnedy, Íde Delargy, Mike Scully, Paula Mayock, William Ebbitt, María Otero Vázquez, Nicola Corrigan, Nicki Killeen, Muriel Pate, Paula Byrne, Gráinne Cousins |
| 41 |
[GO] |
2022―Jun―06 |
“COVID just kind of opened a can of whoop-ass”: The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm reduction services in Canada |
Stephanie Glegg, Karen McCrae, Gillian Kolla, Natasha Touesnard, Jeffrey Turnbull, Thomas D. Brothers, Rupinder Brar, Christy Sutherland, Bernard Le Foll, Andrea Sereda, Marie-Ève Goyer, Nanky Rai, Scott Bernstein, Nadia Fairbairn |
| 42 |
[GO] |
2022―May―27 |
A qualitative study exploring the impact of the COVID-19 pandemic on People Who Inject Drugs (PWID) and drug service provision in the UK: PWID and service provider perspectives |
Tom May, Jo Dawes, Daisy Fancourt, Alexandra Burton |
| 43 |
[GO] |
2022―May―14 |
Impact of COVID-19 on substance use disorder treatment services in Kenya: Qualitative findings from healthcare providers |
Abbe Muller, Matthew J Akiyama, Lindsey Riback, Mercy Nyakowa, Helgar Musyoki, Peter Cherutich, Ann Kurth |
| 44 |
[GO] |
2022―May―04 |
Factors associated with 60-day adherence to “safer supply” opioids prescribed under British Columbia's interim clinical guidance for health care providers to support people who use drugs during COVID-19 and the ongoing overdose emergency |
Marion Selfridge, Kiffer Card, Taylor Kandler, Erin Flanagan, Emily Lerhe, Ash Heaslip, Anne Nguyen, Matthew Moher, Bernie Pauly, Karen Urbanoski, Chris Fraser |
| 45 |
[GO] |
2022―Apr―13 |
Evaluating interventions to facilitate opioid agonist treatment access among people who inject drugs in Toronto, Ontario during COVID-19 pandemic restrictions |
Zachary Bouck, Ayden I. Scheim, Tara Gomes, Vicki Ling, Alexander Caudarella, Dan Werb |
| 46 |
[GO] |
2022―Apr―04 |
Temporal monitoring of stimulants during the COVID-19 pandemic in Belgium through the analysis of influent wastewater |
Tim Boogaerts, Maarten Quireyns, Maarten De prins, Bram Pussig, Hans De Loof, Catharina Matheï, Bert Aertgeerts, Virginie Van Coppenolle, Erik Fransen, Adrian Covaci, Alexander L.N. van Nuijs |
| 47 |
[GO] |
2022―Mar―07 |
Israeli News media coverage of COVID-19 and use of cannabis and tobacco: A case study of inconsistent risk communication |
Sharon R. Sznitman, Nehama Lewis |
| 48 |
[GO] |
2022―Mar―01 |
Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: a population-based time-series analysis |
Sophie A. Kitchen, Tonya J. Campbell, Siyu Men, Nikki Bozinoff, Mina Tadrous, Tony Antoniou, Jennifer Wyman, Dan Werb, Charlotte Munro, Tara Gomes |
| 49 |
[GO] |
2022―Feb―17 |
A rapid ethnographic study of risk negotiation during the COVID-19 pandemic among unstably housed people who use drugs in Rhode Island |
Alexandra B. Collins, Sarah Edwards, Ryan McNeil, Jacqueline Goldman, Benjamin D. Hallowell, Rachel P. Scagos, Brandon D.L. Marshall |
| 50 |
[GO] |
2022―Jan―31 |
COVID-19 economic impact payments and opioid overdose deaths |
Jon E. Sprague, Arthur B. Yeh, Qizhen Lan, Jamie Vieson, Maggie McCorkle |
| 51 |
[GO] |
2022―Jan―31 |
Examining Reactions to Smoking and COVID-19 Risk Messages: An Experimental Study with People Who Smoke |
Zachary B. Massey, Hue T. Duong, Victoria M. Churchill, Lucy Popova |
| 52 |
[GO] |
2022―Jan―25 |
Changes in retrospectively recalled alcohol use pre, during and post alcohol sales prohibition during COVID pandemic in Botswana |
J. Maphisa Maphisa, Kefentse Mosarwane |
| 53 |
[GO] |
2022―Jan―20 |
Methadone Exposures Reported to Poison Control Centers in the United States Following the COVID-19-Related Loosening of Federal Methadone Regulations |
Christopher Welsh, Suzanne Doyon, Katherine Hart |
| 54 |
[GO] |
2022―Jan―05 |
No party, no drugs? Use of stimulants, dissociative drugs, and GHB/GBL during the early COVID-19 pandemic1 |
Antonia Bendau, Leonard Viohl, Moritz Bruno Petzold, Jonas Helbig, Simon Reiche, Roman Marek, Amy Romanello, Daa Un Moon, Rosa Elisa Gross, Dario Jalilzadeh Masah, Stefan Gutwinski, Inge Mick, Christiane Montag, Ricarda Evens, Tomislav Majić, Felix Betzler |
| 55 |
[GO] |
2021―Dec―23 |
Evaluating how has care been affected by the Ontario COVID-19 Opioid Agonist Treatment Guidance: Patients’ and prescribers’ experiences with changes in unsupervised dosing |
Kim Corace, Kelly Suschinsky, Jennifer Wyman, Pamela Leece, Sue Cragg, Sarah Konefal, Priscille Pana, Susan Barrass, Amy Porath, Brian Hutton |
| 56 |
[GO] |
2021―Dec―20 |
Treatment of Hepatitis C Virus among People Who Inject Drugs at a Syringe Service Program During the COVID-19 Response: the Potential Role of Telehealth, Medications for Opioid Use DIsorder and Minimal Demands on Patients |
Anishaa Sivakumar, Lynn Madden, Elizabeth DiDomizio, Anthony Eller, Merceditas Villanueva, Frederick L. Altice |
| 57 |
[GO] |
2021―Dec―09 |
DRUG MARKETS AND COVID-19: A SPATIOTEMPORAL STUDY OF DRUG OFFENCE DETECTION RATES IN BRISBANE, AUSTRALIA |
Jason L. Payne, Cameron T. Langfield |
| 58 |
[GO] |
2021―Dec―08 |
Impacts of changes in alcohol consumption patterns during the first 2020 COVID-19 restrictions for people with and without mental health and neurodevelopmental conditions: A cross sectional study in 13 countries |
Emma L. Davies, Cheneal Puljevic, Gail Gilchrist, Laura Potts, Ahnjili Zhuparris, Larissa J. Maier, Monica J. Barratt, Adam R. Winstock, Jason A. Ferris |
| 59 |
[GO] |
2021―Dec―01 |
The COVID-19 Pandemic and the Health of People Who Use Illicit Opioids in New York City, the First 12 Months |
Alex S. Bennett, Tarlie Townsend, Luther Elliott |
| 60 |
[GO] |
2021―Nov―26 |
Experiences with take-home dosing in heroin-assisted treatment in Switzerland during the COVID-19 pandemic - is an update of legal restrictions warranted? |
Maximilian Meyer, Johannes Strasser, Patrick Köck, Marc Walter, Marc Vogel, Kenneth M. Dürsteler |
| 61 |
[GO] |
2021―Nov―19 |
Experiences with Substance Use Disorder Treatment During the COVID-19 Pandemic: Findings from a Multistate Survey |
Brendan Saloner, Noa Krawczyk, Keisha Solomon, Sean T. Allen, Miles Morris, Katherine Haney, Susan G. Sherman |
| 62 |
[GO] |
2021―Oct―29 |
Trends in cannabis use among U.S. adults amid the COVID-19 pandemic |
Savannah G. Brenneke, Courtney D. Nordeck, Kira E. Riehm, Ian Schmid, Kayla N. Tormohlen, Emily J. Smail, Renee M. Johnson, Luther G. Kalb, Elizabeth A. Stuart, Johannes Thrul |
| 63 |
[GO] |
2021―Sep―29 |
The success rate of online illicit drug transactions during a global pandemic |
Andréanne Bergeron, David Décary-Hétu, Luca Giommoni, Marie-Pier Villeneuve-Dubuc |
| 64 |
[GO] |
2021―Sep―20 |
Twitter Discourse on Nicotine as Potential Prophylactic or Therapeutic for COVID-19 |
Ramakanth Kavuluru, Jiho Noh, Shyanika W. Rose |
| 65 |
[GO] |
2021―Aug―04 |
Cannabis sales increases during COVID-19: Findings from Alaska, Colorado, Oregon, and Washington |
Gillian L. Schauer, Julia A. Dilley, Douglas R. Roehler, Thomas J. Sheehy, Jessica R. Filley, Sara Cooley Broschart, Kristin M. Holland, Grant T. Baldwin, Amy K. Holmes-Chavez, Brooke E. Hoots |
| 66 |
[GO] |
2021―Aug―03 |
Using a “Big Events” framework to understand emergency department use among women experiencing homelessness or housing instability in San Francisco during the COVID-19 pandemic |
Elise D. Riley, Maria C. Raven, Samantha E. Dilworth, Carl Braun, Elizabeth Imbert, Kelly M. Doran |
| 67 |
[GO] |
2021―Jul―20 |
Living Under Coronavirus and Injecting Drugs in Bristol (LUCID-B): a qualitative study of experiences of COVID-19 among people who inject drugs |
Joanna M. Kesten, Adam Holland, Myles-Jay Linton, Hannah Family, Jenny Scott, Jeremy Horwood, Matthew Hickman, Maggie Telfer, Rachel Ayres, Deborah Hussey, Jack Wilkinson, Lindsey A. Hines |
| 68 |
[GO] |
2021―Jul―20 |
Changes in Characteristics of Drug Overdose Death Trends during the COVID-19 Pandemic |
Catherine DiGennaro, Gian-Gabriel P. Garcia, Erin J. Stringfellow, Sarah Wakeman, Mohammad S. Jalali |
| 69 |
[GO] |
2021―Jun―14 |
“I'm pretty sure it's either food poisoning or Covid-19”: Lived experience versus medical knowledge in diagnosing substance use problems |
David Frank |
| 70 |
[GO] |
2021―Jun―08 |
Lessons Learned Recruiting A Diverse Sample of Rural Study Participants During the COVID-19 Pandemic |
Nam Hyo Kim, NeCall Wilson, Trish Mashburn, Lauren Reist, Salisa C. Westrick, Kevin Look, Korey Kennelty, Delesha Carpenter |
| 71 |
[GO] |
2021―May―14 |
Political Partisanship and Stigma Against People Who Use Drugs in Opinions About Allocating COVID-19 Prevention Resources to Vulnerable Populations |
Kristin E. Schneider, Deborah Wilson, Lauren Dayton, Erin M. Anderson Goodell, Carl A. Latkin |
| 72 |
[GO] |
2021―Apr―20 |
Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada |
Farihah Ali, Cayley Russell, Frishta Nafeh, Jürgen Rehm, Sean LeBlanc, Tara Elton-Marshall |
| 73 |
[GO] |
2021―Mar―20 |
Pathways between COVID-19 Public Health Responses and Increasing Overdose Risks: A Rapid Review and Conceptual Framework |
Tribesty Nguyen, Jane A. Buxton |
| 74 |
[GO] |
2021―Mar―06 |
A Free Mailed Naloxone Program in Philadelphia amidst the COVID-19 Pandemic |
Rachel French, Jamie Favaro, Shoshana V. Aronowitz |
| 75 |
[GO] |
2021―Mar―01 |
Multi-level drivers of tobacco use and purchasing behaviors during COVID-19 “lockdown”: A qualitative study in the United States |
Daniel P. Giovenco, Torra E. Spillane, Rachel M. Maggi, Esther Y. Lee, Morgan M. Philbin |
| 76 |
[GO] |
2021―Feb―07 |
“How will I get my next week's script?” Reactions of Reddit opioid forum users to changes in treatment access in the early months of the coronavirus pandemic |
Noa Krawczyk, Amanda M. Bunting, David Frank, Joshua Arshonsky, Yuanqi Gu, Samuel R. Friedman, Marie A. Bragg |
| 77 |
[GO] |
2021―Jan―31 |
Drug-related violence: will COVID-19 drive better data for safer and more secure EU? |
Teodora Groshkova, Marieke Liem, Andrew Cunningham, Roumen Sedefov, Paul Griffiths |
| 78 |
[GO] |
2021―Jan―20 |
A rapid review of the impacts of "Big Events" on risks, harms, and service delivery among people who use drugs: Implications for responding to COVID-19. |
Camille Zolopa, Stine Hoj, Julie Bruneau, Julie-Soleil Meeson, Nanor Minoyan, Marie-France Raynault, Iuliia Makarenko, Sarah Larney |
| 79 |
[GO] |
2021―Jan―14 |
COVID-19 and people who use drugs; Seizing opportunity in times of chaos |
Ernst WISSE, Naomi Burke-Shyne, Judy Chang, Mat Southwell |
| 80 |
[GO] |
2020―Dec―23 |
Evidence of Increased Fentanyl Use During the COVID-19 Pandemic Among Opioid Agonist Treatment Patients in Ontario, Canada |
Kristen A. Morin, Shreedhar Acharya, Joseph K. Eibl, David C. Marsh |
| 81 |
[GO] |
2020―Dec―10 |
Essential work, precarious labour: The need for safer and equitable harm reduction work in the era of COVID-19 |
Michelle Olding, Allison Barker, Ryan McNeil, Jade Boyd |
| 82 |
[GO] |
2020―Nov―24 |
Medication and substance use increases among people using cannabis medically during the COVID-19 pandemic |
Kevin F. Boehnke, Jenna McAfee, Joshua M. Ackerman, Daniel J. Kruger |
| 83 |
[GO] |
2020―Nov―20 |
Possibilities and pitfalls? Moderate drinking and alcohol abstinence at home since the COVID-19 lockdown |
Emily Nicholls, Dominic Conroy |
| 84 |
[GO] |
2020―Nov―09 |
COVID-19 and the health of people who use drugs: What is and what could be? |
Jason Grebely, Magdalena Cerdá, Tim Rhodes |
| 85 |
[GO] |
2020―Nov―07 |
Harm reduction in the time of COVID-19: Case study of homelessness and drug use in Dublin, Ireland |
Austin O'Carroll, Tony Duffin, John Collins |
| 86 |
[GO] |
2020―Oct―27 |
Supplying synthetic opioids during a pandemic: An early look at North America |
Bryce Pardo |
| 87 |
[GO] |
2020―Oct―19 |
Can google trends search inform us about the population response and public health impact of abrupt change in alcohol policy? - a case study from india during the covid-19 pandemic |
Abhishek Ghosh, Fazl e-Roub, Narayanan C Krishnan, Shinjini Choudhury, Aniruddha Basu |
| 88 |
[GO] |
2020―Oct―16 |
Understanding Challenges for Recovery Homes During COVID-19 |
Douglas L. Polcin, Elizabeth Mahoney, Friedner Wittman, Dave Sheridan, Amy A. Mericle |
| 89 |
[GO] |
2020―Aug―26 |
Virtual raves and happy hours during COVID-19: New drug use contexts for electronic dance music partygoers |
Joseph J. Palamar, Patricia Acosta |
| 90 |
[GO] |
2020―Aug―17 |
Coordination, cooperation, and creativity within harm reduction networks in Iran: COVID-19 prevention and control among people who use drugs |
Maryam Alavi, Amir Moghanibashi-Mansourieh, Seyed Ramin Radfar, Sepideh Alizadeh, Fatemeh Bahramabadian, Sara Esmizade, Gregory J. Dore, Farid Barati Sedeh, Abbas Deilamizade |
| 91 |
[GO] |
2020―Aug―15 |
Continuing increased access to buprenorphine in the United States via telemedicine after COVID-19 |
Corey S. Davis, Elizabeth A. Samuels |
| 92 |
[GO] |
2020―Aug―11 |
No “back to normal” after COVID-19 for our failed drug policies |
Pozo Brandon del, Leo Beletsky |
| 93 |
[GO] |
2020―Jul―31 |
No magic pocket: Buying and selling on drug cryptomarkets in response to the COVID-19 pandemic and social restrictions |
Monica J. Barratt, Judith Aldridge |
| 94 |
[GO] |
2020―Jul―30 |
Preliminary findings of the impact of COVID-19 on drugs crypto markets |
Andréanne Bergeron, David Décary-Hétu, Luca Giommoni |
| 95 |
[GO] |
2020―Jul―30 |
Care During COVID-19: Drug Use, Harm Reduction, and Intimacy During a Global Pandemic |
Allison Schlosser, Shana Harris |
| 96 |
[GO] |
2020―Jul―29 |
Drug use during a pandemic: Convergent risk of novel coronavirus and invasive bacterial and viral infections among people who use drugs |
Brendan P. Jacka, Emily Phipps, Brandon D.L. Marshall |
| 97 |
[GO] |
2020―Jul―27 |
Safer opioid distribution in response to the COVID-19 pandemic |
Mark Tyndall |
| 98 |
[GO] |
2020―Jul―21 |
Addressing co-occurring public health emergencies: The importance of naloxone distribution in the era of COVID-19 |
Alexandra B. Collins, Colleen Daley Ndoye, Diego Arene-Morely, Brandon D.L. Marshall |
| 99 |
[GO] |
2020―Jul―15 |
The impact of COVID-19 restrictions on needle and syringe programme provision and coverage in England |
Mark Whitfield, Howard Reed, Jane Webster, Vivian Hope |
| 100 |
[GO] |
2020―Jul―06 |
Isolating the isolated: Implications of COVID-19 quarantine measures on in-patient detoxification treatment for substance use disorders |
Paola Rosca, Barak Shapira, Yehuda Neumark |
| 101 |
[GO] |
2020―Jul―03 |
COVID-19 - Enacting a ‘new normal’ for people who use drugs |
Judy Chang, Jake Agliata, Mauro Guarinieri |
| 102 |
[GO] |
2020―Jul―03 |
Participation of the nursing workforce to address COVID-19 among people who use alcohol, tobacco, and drugs |
Vincent Guilamo-Ramos, Adam Benzekri, Marco Thimm-Kaiser, Marissa Abram, Holly Hagan |
| 103 |
[GO] |
2020―Jul―03 |
Why we should all be more careful in drawing conclusions about how COVID-19 is changing drug markets |
Luca Giommoni |
| 104 |
[GO] |
2020―Jul―02 |
The SARS-Cov-2 threat in Cracolândia, an open-air drug use scene in Brazil |
Felipe B. Arcadepani, Vitor S. Tardelli, Thiago M. Fidalgo |
| 105 |
[GO] |
2020―Jun―22 |
An urgent impetus for action: safe inhalation interventions to reduce COVID-19 transmission and fatality risk among people who smoke crack cocaine in the United Kingdom |
Magdalena Harris |
| 106 |
[GO] |
2020―Jun―12 |
Syringe Services Program (SSP) Operational Changes During the COVID-19 Global Outbreak |
Tyler S. Bartholomew, Nobuyo Nakamura, Lisa R. Metsch, Hansel E. Tookes |
| 107 |
[GO] |
2020―Jun―11 |
The Perfect Storm: COVID-19, mass incarceration and the opioid epidemic |
Trena I. Mukherjee, Nabila El-Bassel |
| 108 |
[GO] |
2020―Jun―03 |
Challenges of providing COVID-19 prevention services to homeless people who use drugs in Iran |
Abbas Deilamizade, Amir Moghanibashi-Mansourieh |
